[1]
|
Qayyum, T., Oades, G., Horgan, P., Aitchison, M. and Edwards, J. (2013) The Epidemiology and Risk Factors for Renal Cancer. Current Urology, 6, 169-174. https://doi.org/10.1159/000343534
|
[2]
|
Frascà, G.M., Brigante, F., Volpe, A., Cosmai, L., Gallieni, M. and Porta, C. (2019) Kidney Transplantation in Patients with Previous Renal Cancer: A Critical Appraisal of Current Evidence and Guidelines. Journal of Nephrology, 32, 57-64. https://doi.org/10.1007/s40620-018-0542-y
|
[3]
|
Usher-Smith, J., Simmons, R.K., Rossi, S.H. and Stewart, G.D. (2020) Current Evidence on Screening for Renal Cancer. Nature Reviews Urology, 17, 637-642. https://doi.org/10.1038/s41585-020-0363-3
|
[4]
|
Mennitto, A., Verzoni, E., Grassi, P., Ratta, R., Fucà, G. and Procopio, G. (2017) Multimodal Treatment of Advanced Renal Cancer in 2017. Expert Review of Clinical Pharmacology, 10, 1395-1402.
https://doi.org/10.1080/17512433.2017.1386552
|
[5]
|
Ji, R., Ren, Q., Bai, S., Wang, Y. and Zhou, Y. (2018) Prognostic Significance of Pretreatment Plasma Fibrinogen Level in Patients with Digestive System Tumors: A Me-ta-Analysis. The International Journal of Biological Markers, 33, 254-265. https://doi.org/10.1177/1724600818773627
|
[6]
|
Ji, R., Ren, Q., Bai, S., Wang, Y. and Zhou, Y. (2018) Prognostic Significance of Pretreatment Plasma Fibrinogen in Patients with Hepatocellular and Pancreatic Carcinomas: A Me-ta-Analysis. Medicine, 97, Article No. e10824.
https://doi.org/10.1097/MD.0000000000010824
|
[7]
|
Lin, J.X., Chen, X.W., Chen, Z.H., Huang, X.Y., Yang, J.J., Xing, Y.F., et al. (2017) A Multidisciplinary Team Approach for Nutritional Interventions Conducted by Specialist Nurses in Patients with Advanced Colorectal Cancer Undergoing Chemotherapy: A Clinical Trial. Medicine, 96, Article No. e7373.
https://doi.org/10.1097/MD.0000000000007373
|
[8]
|
Chen, C., Liu, Y., Han, P. and Cui, B. (2021) Research Pro-gress of Preoperative FPR, FPR or AFR in Patients with Colorectal Cancer. Cancer Management and Research, 13, 1791-801. https://doi.org/10.2147/CMAR.S292605
|
[9]
|
John, A., Gorzelanny, C., Bauer, A.T., Schneider, S.W. and Bolenz, C. (2017) Role of the Coagulation System in Genitourinary Cancers: Review. Clinical Genitourinary Can-cer, 16, E29-E37. https://doi.org/10.1016/j.clgc.2017.07.013
|
[10]
|
Wen, L., Guo, L., Zhang, W., Li, Y., Jiang, W., Di, X., et al. (2019) Cooperation between the Inflammation and Coagulation Systems Promotes the Survival of Circulat-ing Tumor Cells in Renal Cell Carcinoma Patients. Frontiers in Oncology, 9, Article No. 504. https://doi.org/10.3389/fonc.2019.00504
|
[11]
|
Bian, Z., Meng, J., Niu, Q., Jin, X., Wang, J., Feng, X., et al. (2020) Prognostic Role of Prothrombin Time Activity, Prothrombin Time, Albumin/Globulin Ratio, Platelets, Sex, and Fibrino-gen in Predicting Recurrence-Free Survival Time of Renal Cancer. Cancer Management and Research, 12, 8481-8490. https://doi.org/10.2147/CMAR.S264856
|
[12]
|
Martino, M.M., Briquez, P.S.A., Lutolf, M.P. and Hubbell, J.A. (2013) Heparinbinding Domain of Fibrin(ogen) Binds Growth Factors and Promotes Tissue Repair When Incorporated Within a Synthetic Matrix. Proceedings of the National Academy of Sciences of the United States of America, 110, 4563-4568. https://doi.org/10.1073/pnas.1221602110
|
[13]
|
Putelli, A., Kiefer, J.D., Zadory, M., Matasci, M. and Neri, D. (2014) A Fibrin-Specific Monoclonal Antibody from a Designed Phage Display Library Inhibits Clot Formation and Localizes to Tumors in Vivo. Journal of Molecular Biology, 426, 3606-3618. https://doi.org/10.1016/j.jmb.2014.07.023
|
[14]
|
Tupikowski, K., Dembowski, J., Kolodziej, A., Niezgoda, T., Debinski, P., Malkiewicz, B., et al. (2015) Interferon Alpha and Metronomic Cyclophosphamide for Metastatic Kidney Cancer: A Phase 2 Study. Journal of Interferon & Cytokine Research, 35, 367-372. https://doi.org/10.1089/jir.2014.0106
|
[15]
|
Alevizopoulos, A., Tyritzis, S., Leotsakos, I., Anastasopoulou, I., Pour-naras, C., Kotsis, P., et al. (2017) Role of Coagulation Factors in Urological Malignancy: A Prospective, Controlled Study on Prostate, Renal and Bladder Cancer. International Journal of Urology, 24, 130-136. https://doi.org/10.1111/iju.13271
|
[16]
|
Lee, J.L., Oh, E.S., Lee, R.W. and Finucane, T.E. (2015) Serum Albumin and Preal-Bumin in Calorically Restricted, Nondiseased Individuals: A Systematic Review. The American Journal of Medicine, 128, e1021-e1022.
https://doi.org/10.1016/j.amjmed.2015.03.032
|
[17]
|
Liu, X., Sun, X., Liu, J., Kong, P., Chen, S., Zhan, Y., et al. (2015) Preoperative C-Reactive Pro-Tein/albumin Ratio Predicts Prognosis of Patients After Cu-Rative Resection for Gastric Cancer. Translational Oncology, 8, 339-345.
https://doi.org/10.1016/j.tranon.2015.06.006
|
[18]
|
Miura, K., Hamanaka, K., Koizumi, T., Kitaguchi, Y., Terada, Y., Nakamura, D., et al. (2017) Clinical Signifi-Cance of Preoperative Serum Albumin Level for Prognosis in Surgically Resected Patients with Non-Small Cell Lung Cancer: Comparative Study of Normal Lung, Emphysema, and Pulmonary Fibrosis. Lung Cancer, 111, 88-95.
https://doi.org/10.1016/j.lungcan.2017.07.003
|
[19]
|
Ziętarska, M., Krawczyk-Lipiec, J., Kraj, L., Zaucha, R. and Małgorzewicz, S. (2017) Chemotherapy-Related Toxicity, Nutritional Status an D Quality of Life in Precachectic Onco-logic Patients With, or Without, High Protein Nutritional Support. A Prospective, Randomized Study. Nutrients, 9, Arti-cle No. 1108. https://doi.org/10.3390/nu9101108
|
[20]
|
Li, B., Deng, H., Zhou, Z. and Tang, B. (2022) The Prog-nostic Value of the Fibrinogen to Pre-Albumin Ratio in Malignant Tumors of the Digestive System: A Systematic Re-view and Meta-Analysis. Cancer Cell International, 22, Article No. 22. https://doi.org/10.1186/s12935-022-02445-w
|
[21]
|
Sun, D.W., An, L. and Lv, G.Y. (2020) Albumin-Fibrinogen Ratio and Fibrinogen-Prealbumin Ratio As Promising Prognostic Markers for Cancers: An Updated Meta-Analysis. World Journal of Surgical Oncology, 18, Article No. 9.
https://doi.org/10.1186/s12957-020-1786-2
|